• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[用于前列腺增生的汉方制剂:柴苓汤对夜尿症的有效性]

[Kampo preparations for prostatic hyperplasia: usefulness of Saireito for nocturia].

作者信息

Sugiyama Takahide, Oonishi Norio, Onoe Masahiro, Kurita Takashi

机构信息

Department of Urology, Faculty of Medicine, Kinki University.

出版信息

Hinyokika Kiyo. 2002 Jun;48(6):343-6.

PMID:12166233
Abstract

Prostatic hyperplasia is characterized by major voiding symptoms, and treatment aims principally at improving the quality of life. Nocturnal frequency is a primary symptom that markedly impairs the quality of life. In addition to alpha 1-receptor blockers and antiandrogen agents, herbal medicines and kampo preparations have also been used, but they have not always proved satisfactory. In this study, we investigated the effect of a diuretic kampo preparation (Kanebo Saireito Extract Fine Granules) on urine output, and evaluated the efficacy of Saireito (5.4 g/day, bid) in 12 patients (mean age, about 68) with prostatic hyperplasia who had completed basic therapy but still complained of nocturnal frequency. The following results were obtained. 1) Saireito caused a significant increase of daytime urine output and significantly reduced nocturnal output. 2) It significantly reduced the nocturnal frequency, although that of daytime urination remained unchanged. 3) The drug significantly improved symptoms that existed before treatment. These results suggest that Saireito is effective for nocturia in patients with prostatic hyperplasia.

摘要

前列腺增生的特征是主要的排尿症状,治疗主要旨在改善生活质量。夜尿是明显损害生活质量的主要症状。除了α1受体阻滞剂和抗雄激素药物外,草药和汉方药制剂也已被使用,但它们并不总是令人满意。在本研究中,我们研究了一种利尿汉方药制剂(嘉娜宝柴苓汤提取物细颗粒)对尿量的影响,并评估了柴苓汤(5.4克/天,每日两次)对12例(平均年龄约68岁)完成基础治疗但仍有夜尿症状的前列腺增生患者的疗效。获得了以下结果。1)柴苓汤使白天尿量显著增加,夜间尿量显著减少。2)它显著减少了夜尿次数,尽管白天排尿次数保持不变。3)该药物显著改善了治疗前存在的症状。这些结果表明,柴苓汤对前列腺增生患者的夜尿有效。

相似文献

1
[Kampo preparations for prostatic hyperplasia: usefulness of Saireito for nocturia].[用于前列腺增生的汉方制剂:柴苓汤对夜尿症的有效性]
Hinyokika Kiyo. 2002 Jun;48(6):343-6.
2
[The efficacy of Gosyajinkigan for pollakisuria].[桂枝加龙骨牡蛎汤治疗尿频的疗效]
Hinyokika Kiyo. 2006 Mar;52(3):197-201.
3
[Etiology of nocturia and clinical efficacy of naftopidil on nocturia in patients with benign prostatic hyperplasia--analysis of frequency volume charts].
Hinyokika Kiyo. 2004 May;50(5):309-14.
4
Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.两种α1肾上腺素能受体拮抗剂萘哌地尔和盐酸坦索罗辛治疗良性前列腺增生所致下尿路症状的比较:一项随机交叉研究。
BJU Int. 2006 Apr;97(4):747-51, discussion 751. doi: 10.1111/j.1464-410X.2006.06030.x.
5
[Fushile: a safe and effective therapeutic for benign prostatic hyperplasia].[氟西雷:一种治疗良性前列腺增生的安全有效的疗法]
Zhonghua Nan Ke Xue. 2008 Mar;14(3):227-30.
6
[Clinical effects of naftopidil on nocturia associated with benign prostatic hyperplasia].萘哌地尔治疗良性前列腺增生所致夜尿症的临床疗效
Hinyokika Kiyo. 2003 Aug;49(8):445-9.
7
[Long-term efficacy of naftopidil for treatment of lower urinary tract symptoms with benign prostatic hyperplasia].萘哌地尔治疗良性前列腺增生所致下尿路症状的长期疗效
Hinyokika Kiyo. 2003 Apr;49(4):189-93.
8
[The effectiveness of naftopidil in patients with benign prostatic hyperplasia evaluated by QOL index].[通过生活质量指数评估萘哌地尔对良性前列腺增生患者的疗效]
Hinyokika Kiyo. 2007 Jan;53(1):13-8.
9
Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial.良性前列腺增生症药物治疗引起的夜尿变化:退伍军人事务部合作研究试验的二次分析
J Urol. 2003 Jul;170(1):145-8. doi: 10.1097/01.ju.0000069827.09120.79.
10
Clinical observations of the effect of antidiuretic hormone on nocturia in elderly men.抗利尿激素对老年男性夜尿症影响的临床观察
BJU Int. 2005 Dec;96(9):1310-3. doi: 10.1111/j.1464-410X.2005.05829.x.